CheckPoint Therapeutics Inc (CKPT): Checkpoint Therapeutics Submits Biologic...

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

CheckPoint Therapeutics Inc (CKPT)

Reply Private New

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	227
Posts	28505
Boards Moderated	1
Alias Born	05/30/2012

Re: vein post# 116

Wednesday, 01/04/2023 2:31:09 PM

Wednesday, January 04, 2023 2:31:09 PM

Checkpoint Therapeutics Submits Biologics License Application for Skin Cancer Therapy

MT NEWSWIRES

11:27 AM ET 01/04/2023

11:27 AM EST, 01/04/2023 (MT Newswires) -- Checkpoint Therapeutics (CKPT) said Wednesday it has submitted a biologics license application to the US Food and Drug Administration for the approval of cosibelimab to treat patients with metastatic cutaneous squamous cell carcinoma or locally advanced cSCC who are not candidates for curative surgery or radiation.

The application is backed by positive efficacy and safety data from its ongoing trial of cosibelimab, the company said.

Shares of Checkpoint Therapeutics (CKPT) rose more than 6% in recent trading activity.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent CKPT News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/02/2024 01:30:12 AM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/05/2024 10:00:39 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2024 01:15:17 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 10:15:50 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/30/2024 10:10:40 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 10:00:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 10:01:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 12:10:40 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/17/2023 10:02:12 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/17/2023 10:01:35 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 10:15:39 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 10:10:18 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 09:00:26 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:36:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 08:30:46 PM
Fortress Biotech Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 08/14/2023 08:01:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 12:28:56 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/31/2023 12:23:22 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/27/2023 11:30:13 AM
Fortress Biotech Reports First Quarter 2023 Financial Results and Recent Corporate Highlights • GlobeNewswire Inc. • 05/15/2023 08:01:31 PM

More CKPT News

InvestorsHub NewsWire

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM

Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM

Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM

Start posting your company's news

Only $200 per official company press release!

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow